T-cell dependent pathways in rheumatoid arthritis

Current Opinion in Rheumatology

Volumn 9, Issue 3, 1997, Pages 236-240

  Panayi, G S ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CYTOKINE;

DISEASE COURSE; DOWN REGULATION; FIBROBLAST; HELPER CELL; MACROPHAGE; MESENCHYME; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; T LYMPHOCYTE; TRANSCRIPTION REGULATION;

ARTHRITIS, RHEUMATOID; AUTOANTIGENS; CYTOKINES; HUMANS; JOINTS; MODELS, BIOLOGICAL; SYNOVITIS; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 0030928325     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-199705000-00010     Document Type: Review

References (36)

1. Panayi GS, Lanchbury JS, Kingsley GH: The importance of the T cell in inititiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992, 35:729-735.
2. Aho K, Essen R, Kurki P, Palosuo T, Heliovaara M: Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. J Rheumatol 1993, 20:1278-1281.
3. Sebbag M, Simon M, Vincent C, Masson-Bessiere C, Girbal E, Durieux J: The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995 95:2672-2679.
4. Berthelot JM, Maugars Y, Audrain M, Youinou P, Prost A: Specificity of antiperinuclear factor for rheumatoid arthritis in rheumatoid factor-positive sera. Br J Rheumatol 1995, 34:716-720.
5. McColl GJ, Cram DS, Harrison LC: Antibodies to synovial antigens in recent-onset rheumatoid arthritis. Arthritis Rheum 1995, 38:1418-1428.
6. Kirschmann D, Duffin KL, Smith CE, Welply JR, Howard SC, Schwartz BD, Woulfe SL: Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J Immunol 1995, 155:5655-5662. Invariant chain prevents peptide loading of HLA-DR molecules during their synthesis within the cell. Invariant peptides were eluted from the groove of HLA-DR molecules on the surface of the cells. This implies that autoantigens would be less likely to be loaded onto the antigen-presenting groove. However, there was found to be a lack of invariant chain peptides eluted from DRB1*0401 and DRB1*0404 cell surface molecules, perhaps permitting increased autoantigenic peptide loading.
7. Thomas R, Davis LS, Lipsky PE: Rheumatoid synovium is enriched in mature antigen-presenting dendritic cells. J Immunol 1994, 152:2613-2623.
8. Liu MF, Kohsaka H, Sakurai H, Azuma M, Okumura K, Saito I, Miyasaka N: The presence of costimulatory molecules CD86 and CD28 in rheumatoid arthritis synovium. Arthritis Rheum 1996, 39:110-114.
9. Balsa A, Dixey J, Sansom DM, Maddison PJ, Hall ND: Differential expression of the costimulatory molecules B7.1 (CD80) and B7.2 (CD86) in rheumatoid synovial tissue. Br J Rheumatol 1996, 35:33-37.
10. Verwilghen J, Vertessen S, Stevens EAM, Dequeker J, Ceuppens JL: Depressed T cell reactivity to recall antigens in rheumatoid arthritis. J Clin Immunol 1990, 10:90-96.
11. Kirkham BW, Pitzalis C, Kingsley GH, Timms AM, Kyriazis N, Panayi GS: Rheumatoid T lymphocyte MHC class II expression: in vitro stimulation produces normal MHC class II expression, independent of proliferation. J Rheumatol 1989, 16:270-274.
12. Tsai C, Diaz LA, Jr, Singer NG, Li LL, Kirsch AH, Mitra R, Nickoloff BJ, Crofford LJ, Fax DA: Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum 1996, 39:125-136. Cultured rheumatoid synoviocytes can perform some of the functions of professional antigen-presenting cells. If similar properties are exhibited in vivo, then synoviocytes could, in addition to their other functions, contribute to the ongoing immune responses within the synovium.
13. Hasler F, Dayer JM: Diminished II-2-induced gamma-interferon production by unstimulated peripheral blood lymphocytes in rheumatoid arthritis. Br J Rheumatol 1988, 27:15-20.
14. Howell WM, Warren CJ, Cook NJ, Cawley MI, Smith JL: Detection of IL-2 at mRNA and protein levels in synovial infiltrates from inflammatory arthropathies using biotinylated oligonucleotide probes in situ. Clin Exp Immunol 1991, 86:393-398.
15. Chen E, Keystone EC, Fish EN: Restricted cytokine expression in rheumatoid arthritis. Arthritis Rheum 1993, 36:901-910.
16. Isler P, Vey E, Zhang J, Dayer J: Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69. Eur Cytokine Netw 1993, 4:15-23.
17. Miltenburg AM, Lacraz S, Wilgus HG, Dayer J: Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts. J Immunol 1995, 154:2655-2667.
18. Lavelle-Jones M, Al-Hadrani A, Spiers EM, Campbell FC, Cuschieri A: Reactivation of rheumatoid arthritis during continuous infusion of interleukin-2: evidence of lymphocytic control of rheumatoid disease. BMJ 1990, 301:97.
19. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 1987, 17:1411-1416.
20. Jendro MC, Ganten T, Matteson EL, Weyand CM, Goronzy JJ: Emergence of oligoclonal T cell populations following therapeutic T cell depletion in rheumatoid arthritis. Arthritis Rheum 1995, 38:1242-1251.
21. Choy EHS, Panayi GS, Kingsley GH: Therapeutic monoclonal antibodies. Br J Rheumatol 1995, 34:707-715.
22. Lai NS, Lan JL, Yu CL, Lin RH: Role of tumor necrosis factor-alpha in the regulation of activated synovial T cell growth: down-regulation of synovial T cells in rheumatoid arthritis patients. Eur J Immunol 1995, 25:3243-3248. Synovial T cells from patients with rheumatoid arthritis accumulate in S-phase after mitogen stimulation. This block can be reserved with antihuman TNF-α monoclonal antibody and soluble human TNF receptor. These data indicate that TNF-α could regulate activated synovial T-cell growth by driving them into S-phase. It could be one mechanism in downregulating activation of synovial T cells.
23. Cope AP, Londei M, Chu NR, Cohen SBA, Elliot MJ, Brennan FM, Maini RN, Feldman M: Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis. J Clin Invest 1994, 94:749-760.
24. Bucht A, Larsson P, Weisbrot L, Thorne C, Pisa P, Smedgard G, Keystone EC, Gronberg A: Expression of interferon-gamma (IFN-gamma), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996, 103:357-367.
25. Katsikis PD, Chu C, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 1994, 179:1517-1527.
26. Kitani A, Nakashima N, Matsuda T, Xu B, Yu S, Nakamura T, Matsuyama T: T cells bound by vascular cell adhesion molecule-1/CD106 in synovial fluid in rheumatoid arthritis: inhibitory role of soluble vascular cell adhesion molecule-1 in T cell activation. J Immunol 1996, 156: 2300-2308.
27. Panayi GS: T cell hypothesis in rheumatoid arthritis (RA) testing by humanised non-depleting anti-CD4 monoclonal antibody (mAb) treatment:1: suppression of disease activity and acute phase response. Arthritis Rheum 1996, 39.
28. Levy R: Results of a placebo-controlled, multicenter trial using a primatised non-depleting, anti-CD4 monoclonal antibody in the treatment of rheumatoid arthritis. Arthritis Rheum 1996, 39.
29. Ikeda Y, Masuko K, Nakai Y, et al.: High frequencies of identical T cell clonotypes in synovial tissues of rheumatoid arthritis patients suggest the occurrence of common antigen-driven Immune responses. Arthritis Rheum 1996, 39:446-453.
30. Mima T, Saeki Y, Ohsima S: Transfer of rheumatoid arthritis into severe combined immunodeficient mice: the pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints. J Clin Invest 1995, 96:1746-1758.
31. Dolhain RJ, Ter Haar NT, Hoefakker S, Tak PP, de Ley M, Ciaassen E, Breedveld FC, Miltenburg AM: Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovlum of patients with osteoarthritis. Br J Rheumatol 1996, 35:24-32.
32. Pernis A, Gupta S, Gollob KJ, Gardein E, Coffman RL, Schindler C, Rothman P: Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells [see comments]. Science 1995, 269:245-247.
33. McInnes IA, Al-Mughales J, Field M, Leung F-P, Dixon R, Sturrock RD, Wilkinson PC, Liew FY: The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996, 2:175-182.
34. Duke O, Panayi GS, Janossy G, Poulter LW: An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin Exp Immunol 1982, 49:22-30.
35. Savill CM, Delves PJ, Kioussis D, Walter P, Lydyard P, Colaco B, Shipley M, Roitt IM: A minority of patients with rheumatoid arthritis show a dominant rearrangement of T-cell receptor beta chain genes in synovial lymphocytes. Scand J Immunol 1987, 25:629-635.
36. Wang F, Sengupta TK, Zhong Z, Ivashkiv LB: Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids. J Exp Med 1995, 182:1825-1831. Many cytokines activate signal transducer and activation of transcription (STAT transcription factors), which activate transcription of inflammatory infector genes. The STATs activated depend on the cytokines being produced. There is an altered balance of STAT1 and STAT3 transcriptional activity in the rheumatoid joint.